Post-Conference Report

Discover the ultimate guide to oncolytic viruses abstracts presented at the annual meeting. This report is divided into two sections: analysis and summary.

In the analysis section, delve into the breakdown of viral families, types of abstracts, trial phases, and disease indications, providing a comprehensive overview of the landscape.

The summary section offers detailed tables categorizing preclinical and clinical abstracts by Trial Sponsor, Abstract ID, Trial ID, Disease Indication, Efficacy Results, Description/Dosing, and Safety Results, ensuring you gain critical insights at a glance.

Don’t miss out on this essential resource that promises to deepen your understanding of oncolytic viruses and inform your strategic decisions effectively.



Download Now

Beacon Oncolytic Viruses

How the most complete oncolytic viruses database can help you

What we cover

Beacon Oncolytic Viruses is a manually curated database solution that includes all publicly available data for preclinical, active, approved, and discontinued virus-based therapies being developed for oncology indications. The database covers:

  • Genetically modified or naturally occurring oncolytic virus-based therapies
  • Virus based therapeutics including therapeutic viral-vaccines

New data expansionDeals and Companies. Gain unparalleled access to in-depth company profiles and the latest commercial deals. Monitor your competitors and opportunities as well as benchmark deals and evaluate potential partners. Learn more about Deals and Companies data by downloading the factsheet.

How Beacon Oncolytic Viruses works

Search the clinical trial and drug landscape by virus type and family, genome types, transgenes, genes deleted or modified for pathway or signalling alteration, envelope modifications, or promoter related modifications, routes of administration, diseases, biomarkers, line of therapy, instantaneously and/or extract the data points you need to conduct more complex analyses.

Our unique Milestones filter and visualization highlights past, present, and future drug development milestones including drug and trial readouts, asset history, and regulatory announcements. This enhancement provides an accurate, timely and exhaustive single-drug timeline allowing you to benchmark progress in the oncolytic viruses space.

Find out more

Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.

With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.

Discover a database tailored to your needs

At Beacon, we are committed to empowering our pharmaceutical and biotech industry partners with accurate, comprehensive data. We are not just a tool; we see ourselves as a partner in the drug development journey. Contact us to learn how we help you.


Get started